Guanabenz

Guanabenz

Clinical data
AHFS/Drugs.com	Consumer Drug Information
MedlinePlus	a686003
Pregnancy category	US: C (Risk not ruled out)
ATC code	none
Pharmacokinetic data
Protein binding	90%
Elimination half-life	6 hours
Identifiers
IUPAC name 2-(2,6-dichlorobenzylidene)hydrazinecarboximidamide
CAS Number	5051-62-7
PubChem CID	5702063
DrugBank	DB00629 Y
ChemSpider	4642445 Y
UNII	GGD30112WC
KEGG	D04375 Y
ChEMBL	ChEMBL420 Y
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C8H8Cl2N4
Molar mass	231.081 g/mol
3D model (JSmol)	Interactive image
SMILES Clc1cccc(Cl)c1\C=N\N=C(/N)N
InChI InChI=1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14)/b13-4+ Y Key:WDZVGELJXXEGPV-YIXHJXPBSA-N Y
(verify)

WikiDoc Resources for Guanabenz
Articles
Most recent articles on Guanabenz Most cited articles on Guanabenz Review articles on Guanabenz Articles on Guanabenz in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Guanabenz Images of Guanabenz Photos of Guanabenz Podcasts & MP3s on Guanabenz Videos on Guanabenz
Evidence Based Medicine
Cochrane Collaboration on Guanabenz Bandolier on Guanabenz TRIP on Guanabenz
Clinical Trials
Ongoing Trials on Guanabenz at Clinical Trials.gov Trial results on Guanabenz Clinical Trials on Guanabenz at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Guanabenz NICE Guidance on Guanabenz NHS PRODIGY Guidance FDA on Guanabenz CDC on Guanabenz
Books
Books on Guanabenz
News
Guanabenz in the news Be alerted to news on Guanabenz News trends on Guanabenz
Commentary
Blogs on Guanabenz
Definitions
Definitions of Guanabenz
Patient Resources / Community
Patient resources on Guanabenz Discussion groups on Guanabenz Patient Handouts on Guanabenz Directions to Hospitals Treating Guanabenz Risk calculators and risk factors for Guanabenz
Healthcare Provider Resources
Symptoms of Guanabenz Causes & Risk Factors for Guanabenz Diagnostic studies for Guanabenz Treatment of Guanabenz
Continuing Medical Education (CME)
CME Programs on Guanabenz
International
Guanabenz en Espanol Guanabenz en Francais
Business
Guanabenz in the Marketplace Patents on Guanabenz
Experimental / Informatics
List of terms related to Guanabenz

For patient information regarding Guanabenz, click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Guanabenz (pronounced GWAHN-a-benz, sold under the trade name Wytensin) is an alpha agonist of the alpha-2 type that is used as an antihypertensive drug. It is used to treat high blood pressure (hypertension).

The most common side effects during guanabenz therapy are dizziness, drowsiness, dry mouth, headache and weakness.

Guanabenz can make one drowsy or less alert, therefore driving or operating dangerous machinery is not recommended.